Olfactory dysfunction in Parkinson's disease

Journal of Neurology Neurosurgery and Psychiatry

Volumn 62, Issue 5, 1997, Pages 436-446

  Hawkes, C H ^a,b   Shephard, B C ^a   Daniel, S E ^b  

^a Department of Clinical Neurology ^*  (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Olfactory evoked potentials; Parkinson's disease; Smell identification

Indexed keywords

CARBON DIOXIDE; HYDROGEN SULFIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EVOKED RESPONSE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN EXPERIMENT; LEWY BODY; MALE; OLFACTORY BULB; OLFACTORY DISCRIMINATION; OLFACTORY NUCLEUS; PARKINSON DISEASE; PRIORITY JOURNAL; SMELLING;

EID: 0030925859     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.62.5.436     Document Type: Article

References (35)

1. Doty RL, Deems DA, Stellar S. Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage or disease duration. Neurology 1988; 38:1237-44.
2. Kobal G, Plattig KH. Methodische Anmerkungen zur Gewinnung olfaktorischer EEG-Antworten des wachen Menschen (objektive Olfaktometrie). Z EEG-EMG 1978; 9:135-45.
3. Hawkes CH, Kobal G, Shephard B. The olfactory evoked response and evidence of disordered olfaction in multiple sclerosis. J Neurol Neurosurg Psychiatry 1992;55:243.
4. Chui HC, Mortimer JA, Slager U, Zarow C, Bondareff W, Webster DD. Pathological correlates of dementia in Parkinson's disease. Arch Neurol 1986;43:991-5.
5. Doty RL, Shaman P, Dann M. Development of the University of Pennsylvania smell identification test: a standardised microencapsulated test of olfactory function. Physiol Behav 1984;32:489-502.
6. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-4.
7. Levine HL. The office diagnosis of nasal and sinus disorders using rigid nasal endoscopy. Otolaryngol Head Neck Surg 1990;102:370-3.
8. Doty RL, Stern MB, Pfeiffer C, Gollomp SM, Hurtig HI. Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1992;55:138-42.
9. Quinn NP, Rossor MN, Marsden CD. Olfactory threshold in Parkinson's disease. J Neurol Neurosurg Psychiatry 1987;50:88-9.
10. Amsterdam JD, Gregg Settle R, Doty RL, Abelman E, Winookur A. Taste and smell perception in depression. Biol Psychiatry 1987;22:1481-5.
11. Kobal G. A new method for determination of the olfactory and the trigeminal nerve's dysfunction: olfactory (OEP) and chemical somatosensory (CSEP) evoked potentials. In: A Rothenberger, ed. Event related potentials in children. Amsterdam: Elsevier, 1982:455-61.
12. Kobal G, Hummel G. Cerebral chemosensory evoked potentials elicited by chemical stimulation of the human olfactory and respiratory nasal mucosa. Electroencephalogr Clin Neurophysiol 1988;71:241-50.
13. Kobal G, Hummel T. Olfactory evoked potentials in humans. In: Getchell TV, Doty RL, Bartoshuk, Snow JB, eds. Smell and taste in health and disease. New York: Raven Press, 1991;13:269-70.
14. Doty RL, Bromley SM, Stern MB. Olfactory testing as an aid in the diagnosis of Parkinson's disease: development of optimal discrimination criteria. Neurodegeneration 1995;4:93-7.
15. Amoore JE, Pelosi P, Forrester LJ. Specific anosmias to 5-androst-16-en-3-one and -pentadecalactone: the urinous and musky primary odours. Chemical Senses and Flavor 1977;2:401-25.
16. Pinching AJ, Døving KB. Selective degeneration in the rat olfactory bulb following exposure to different odours. Brain Res 1974;82:195-204.
17. Hoehn M, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-42.
18. Daniel SE, Hawkes CH. Preliminary diagnosis of Parkinson's disease using olfactory bulb pathology [letter]. Lancet 1992;340:186.
19. Esiri MM, Wilcock GK. The olfactory bulbs in Alzheimer's disease. J Neurol Neurosurg Psychiatry 1984;47:56-60.
20. Mann DMA, Tucker CM, Yates PO. Alzheimer's disease: an olfactory connection? Mech Ageing Dev 1988;42: 1-15.
21. Yoshimura N. Olfactory bulb involvement in Pick's disease. Acta Neuropathologica 1988;77:202-5.
22. Tomlinson AH, Esiri MM. Herpes simplex encephalitis: immuno-histological demonstration of spread of virus via olfactory pathways in mice. J Neurol Sci 1983;60:473-84.
23. Shipley MT. Transport of molecules from nose to brain: transneuronal anterograde and retrograde labelling in the rat olfactory system by wheatgerm agglutin-horseradish peroxidase applied to the nasal epithelium. Brain Res Bull 1985;15:129-42.
24. Buxton PH, Hayward M. Polyneuritis cranialis associated with industrial trichloroethylene exposure. J Neurol Neurosurg Psychiatry 1967;30:511-8.
25. Calne DB, Eisen A, McGeer E, Spencer PS. Alzheimer's disease, Parkinson's disease and motor neurone disease; abiotrophic interaction between ageing and environment? Lancet 1986;ii:1067-70
26. Smith CAD, Gough AC, Leigh PN, Summers B, et al. Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson' disease. Lancet 1992;339: 1375-7.
27. Hext PM, Lock EA. The accumulation and metabolism of 3-trifluoromethylpyridine by rat olfactory and hepatic tissues. Toxicology 1992;72:61-75.
28. Ding X, Coon MJ. Immunochemical characterisation of multiple forms of cytochrome P-450 in rabbit nasal microsomes and evidence for tissue specific expression of P-450s NMa and NMb. Cellular Pharmacology 1990; 37:489-96.
29. Stott WT, Ramsey JC, McKenna MJ. Absorption of chemical vapours by the upper respiratory tract of rats. In: CS Barrow, ed. Toxicology of the nasal passages. Washington, DC: Hemisphere Publishing Corporation, 1986:191-210.
30. Schlesinger RB. Comparative deposition of inhaled aerosols in experimental animals and humans: a review. J Toxicol Environ Health 1985;15:197-214.
31. Bond JA. Bioactivation and biotransformation of xenobiones in rat nasal tissue. In: CS Barrow, ed. Toxicology of the nasal passages. Washington DC: Hemisphere Publishing Corporation, 1986:249-61.
32. Dahl AR. Possible consequences of cytochrome P-450 dependent monpoxygenases in nasal tissues. In: CS Barrow, ed. Toxicology of the nasal passages. Washington DC: Hemisphere Publishing Corporation, 1986:263-73.
33. Dahl AR. The effect of cytochrome P-450-dependent metabolism and other enzyme activities in olfaction. In: Margolis FL, Getchell TV, eds. Molecular neurobiology of the olfactory system. New York: Plenum Press, 1988: 51-70.
34. Gillner M, Brittebo EB, Brandt I, Soderkvist P, Appelgren L-E, Gustafsson J-A. Uptake and specific binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the olfactory mucosa of mice and rats. Cancer Res 1987;47;4150-9.
35. Brittebo EB, Eriksson VF, Bakke J and Brandt I. Toxicity of 2,6-dichlorothiobenzamide (chlorthiamid) and 2,6-dichlorobenzamide in the olfactory nasal mucosa of mice. Fundam Appl Toxicol 1991;17:92-102.